CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
On-treatment and projected sustained viral responses with boceprevir-based triple therapy in previous treatment-failure HCV patients with advanced fibrosis or cirrhosis. Interim analysis of the Hungarian named patient program cohort
DOI 10.1055/s-0033-1347476
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Hunyady, M Abonyi, K Csefkó, A Haragh, G Horváth, V Jancsik, M Makara, E Makkai, Z Müller, Z Ozsvár, P Ribiczey, B Sipos, O Szabó, F Szalay, L Szentgyörgyi, E Újhelyi, M Varga, G Weisz
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and Aims: Efficacy and safety of boceprevir+peginterferon/ribavirin (B+PR) therapy in pervious treatment failure HCV genotype 1 pts with advanced liver fibrosis (F3) or cirrhosis (F4) have been analyzed, with special attention to previous null-responder cirrhotics. Methods: Real life data of the Hungarian Boceprevir Named Patient Program have been retrospectively collected. Treatment: 4-weeks PR lead-in,…
Zitieren
Zitierempfehlung
B Hunyady, M Abonyi, K Csefkó, A Haragh, G Horváth, V Jancsik, M Makara, E Makkai, Z Müller, Z Ozsvár, P Ribiczey, B Sipos, O Szabó, F Szalay, L Szentgyörgyi, E Újhelyi, M Varga, G Weisz (2013) On-treatment and projected sustained viral responses with boceprevir-based triple therapy in previous treatment-failure HCV patients with advanced fibrosis or cirrhosis. Interim analysis of the Hungarian named patient program cohort. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0033-1347476
Mit CareLit weiterarbeiten